About Us

Company Overview

PulManage, Inc. has identified a substantial market opportunity in respiratory care, with a global addressable market (TAM) of $300 billion. The company aims to tackle various challenges in respiratory care, including accurate diagnosis, disease management, and access to real-time data trends for decentralized clinical trial data collection.

Through its platform, PulManage is pioneering a new approach to care delivery by enabling remote respiratory biomarker collection and analysis.

The core innovation lies in its ability to facilitate accurate diagnosis, remote monitoring for significant changes, and forecasting change in chronic respiratory conditions through data modeling.

Ultimately, PulManage aims to enhance patient outcomes and significantly reduce healthcare costs, offering potential investors and partners a promising financial return.

Amanda Clark, RCP, RRT

Founder & CEO of PulManage, Inc. | Seasoned Clinician Bringing Change to Care Delivery Models

What Makes Us Different

  • Daily Remote Spirometry with real-time insights
  • Integrated ePROs & Wearables for holistic patient data
  • Virtual RT Support for higher-quality, repeatable results
  • SOC2 + HIPAA Compliance for security and trust
  • Flexible, API-Driven SaaS Platform built for scalability

The Smarter Way to Run Respiratory Trials

The PulManage software platform connects patients and provider's to accomplish the following:

  • Lower overall cost
  • Create an additional revenue stream
  • Increase quality of life for patients

Providing a web portal for clinicians and mobile application paired with a BT lung function device for patients.

The system sends signals designed to allow providers to confirm obstructive patterns and stay connected to patients at risk of exacerbation.

Ready to talk? Book An Appointment

PulManage Provides a SaaS Platform for High Quality Home Spirometry

with Personalized User Interface, Analytics, and Hardware Deployed in the Home

HIPAA

Data Privacy

AWS Certified

SOC2

QMS